Clinical Trial to Compare ReJoinTM to Sodium Hyaluronate Injection for Knee Osteoarthritis Cartilage Defects

• Status: Unknown status
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effectiveness of ReJoinTM for the Knee Osteoarthritis patients with Cartilage Defects comparing to Sodium Hyaluronate Injection.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cellular Biomedicine Group Ltd.
• Collaborator: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
• Treatments: Hyaluronic Acid

Criteria

Inclusion Criteria:

• 18-70 years old, KOA couse ≤ 10 years

• Kellgren-Lawrence Ⅰ-Ⅲ

• VAS core >6， more than 4 months

• Signed informed consent from the subject

• cartilage defect 2-6cm2

Exclusion Criteria:

• Pregnancy test positive.

• Subject infected with hepatitis C, HIV or syphilis.

• Subject enrolled in any other cell therapy studies within the past 30 days.

• Subject deemed to be not suitable for the study by the investigator